Waters and NIBRT form partnership

March 30, 2012

LCGC Europe eNews

LCGC Europe eNews-03-30-2012, Volume 0, Issue 0

Waters (Milford, Massachusetts, USA) has announced that it has formed a partnership with the Irish National Institute for Bioprocessing Research and Training (NIBRT) to address the world?s most challenging diseases through training and research.

Waters (Milford, Massachusetts, USA) has announced that it has formed a partnership with the Irish National Institute for Bioprocessing Research and Training (NIBRT) to address the world’s most challenging diseases through training and research.

Together Waters and NIBRT have established the Complete Product and Processing Characterization Facility (CPPCF) that will provide laboratory-based scientific training and retraining of ‘fit-for-purpose’ biopharmaceutical analysis. The facility will also educate scientists on current and future US and European drug regulations.

The partnership also establishes NIBRT as a Waters Centre of Innovation in the area of glycobiology research.

Mr Sean Sherlock TD, Minister for Research and Innovation, Department of Jobs, Enterprise and Innovation, said, “The combination of Pauline Rudd's [NIBRT’s principal investigator] expertise in glycan analysis and Waters technology for analysis of complex biological samples provides a unique combination of capabilities that can help underpin Ireland's continued reputation as a centre of excellence for the very highest quality standards in biopharmaceutical manufacturing. I'm truly delighted to announce this collaboration as it will surely assist both NIBRT and Waters in further cementing their reputation as providers of choice for the biopharmaceutical industry and Ireland's reputation as a world leading location for biotech manufacturing.”

NIBRT's interim director, Professor Ian Marison, commented, “This partnership will enable NIBRT, with the help of Waters, to provide advanced solutions for the pharmaceutical industry, including protein characterization, N- and O- glycan analysis.”

For more information please visit ref="http://www.waters.com">www.waters.com

Related Content:

News